Cancer cell-targeted drug delivery utilizing oligopeptide transport activity

International Journal of Cancer

Volumn 88, Issue 2, 2000, Pages 274-280

  Nakanishi, Takeo ^a,b   Tamai, Ikumi ^a,b   Takaki, Akiyoshi ^a   Tsuji, Akira ^a,b  

^a KANAZAWA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BESTATIN; CARNOSINE; OLIGOPEPTIDE;

ARTICLE; CANCER CELL; CANCER INHIBITION; DRUG DELIVERY SYSTEM; EXTRACELLULAR SPACE; HELA CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN TRANSPORT; SOLID TUMOR;

ANIMAL; BIOLOGICAL TRANSPORT; CARBON RADIOISOTOPES; CARNOSINE; CARRIER PROTEINS; DIPEPTIDES; DRUG CARRIERS; HELA CELLS; HUMAN; INSULIN; K562 CELLS; MICE; MICE, NUDE; OLIGOPEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPPORT, NON-U.S. GOV'T; TISSUE DISTRIBUTION; TRANSFECTION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0033813664     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20001015)88:2<274::AID-IJC20>3.0.CO;2-5     Document Type: Article

References (40)

1. Pharmacokinetics of bestatin and oral activity for treatment of experimental metastases
2. Aminopeptidase activities on the surface of mammalian cells
3. Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, Valacyclovir
4. Expression cloning and functional characterization of the kidney cortex high-affinity proton-coupled peptide transporter
5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
6. Human dipeptide transporter, hPEPT1, stably transfected into Chinese hamster ovary cells
7. Carnosine and related substances in animal tissues
8. An oligopeptide transporter is expressed at high level in the pancreatic carcinoma cell lines AsPc-1 and Capan-2
9. Intestinal Absorption of captopril in rats
10. Growth inhibitory effect of bestatin on choriocarcinoma cell lines in vitro
11. Determination of bestatin in serum by high-performance liquid chromatography fluorescence detection
12. Antitumor cells found in tumor-bearing mice given ubenimex
13. Effect of bestatin on mouse immune system and experimental murine tumors
14. Mitogenic effect of bestatin on lymphocytes
15. Specificity and distribution of mammalian carnosinase
16. +/peptide cotransporter
17. +/peptide cotransporter family, from human kidney
18. Enzymatic and immunological evidence for two forms of carnosinase in the mouse
19. Effect of enzyme inhibitors in inhibiting the growth and inducing the differentiation of human promyelocytic leukemia cells, HL-60
20. Sequence, tissue distribution and developmental change in rat intestinal oligopeptide transporter
21. Carrier-mediated transport of oligopeptides in the human fibrosarcoma cell line HT-1080
22. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
23. Immunotherapy with bestatin for acute non-lymphocytic leukemia in adults
24. Development of anti-p185 HER2 immunoliposomes for cancer therapy
25. Recombinant toxins for cancer treatment
26. Immunolocalization and pharmacological relevance of oligopeptide transporter PepT1 in intestinal absorption of β-1actam antibiotics
27. Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2
28. +/peptide cotransporter mediating absorption of beta-lactam antibiotics in the intestine and kidney
29. Molecular cloning and tissue distribution of rat peptide transporter
30. Stimulatory effect of bestatin, a new specific inhibitor of aminopeptidases, on the blastogenesis of guinea pig lymphocytes
31. Studies on the mechanisms of action of the immunomodulator bestatin in various screening systems
32. The predominant contribution of oligopeptide transporter PepT1 to intestinal absorption of β-lactam antibiotics in the rat small intestine
33. Improvement of L-dopa absorption by dipeptidyl derivation, utilizing peptide transporter PepT1
34. +/peptide cotransporter PEPT1: Localization of PEPT1 and transport of β-1actam antibiotics
35. +/dipeptide cotransport system
36. Physiologically based pharmacokinetic model for β-lactam antibiotics I: Tissue distribution and elimination in rat
37. Bestatin, an inhibitor of aminopeptidase B produced by actinomycetes
38. Enhancement of delayed-type hypersensitivity by bestatin, an inhibitor of amin-opeptidases B and leucine aminopeptidases
39. Monoclonal antibodies and therapy
40. Direct antitumot activity of biological response modifiers (B.R.M.) proven by an in vitro sensitivity test